Milestone Pharmaceuticals Inc (MIST)
1.74
-0.01
(-0.57%)
USD |
NASDAQ |
May 17, 16:00
1.74
0.00 (0.00%)
After-Hours: 20:00
Milestone Pharmaceuticals Shareholders Equity (Quarterly): 39.92M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 39.92M |
| December 31, 2023 | 16.77M |
| September 30, 2023 | 28.50M |
| June 30, 2023 | 40.41M |
| March 31, 2023 | 53.94M |
| December 31, 2022 | 66.35M |
| September 30, 2022 | 77.16M |
| June 30, 2022 | 86.66M |
| March 31, 2022 | 100.76M |
| December 31, 2021 | 112.60M |
| September 30, 2021 | 127.42M |
| Date | Value |
|---|---|
| June 30, 2021 | 139.59M |
| March 31, 2021 | 131.99M |
| December 31, 2020 | 143.12M |
| September 30, 2020 | 102.20M |
| June 30, 2020 | 88.02M |
| March 31, 2020 | 99.63M |
| December 31, 2019 | 114.92M |
| September 30, 2019 | 132.83M |
| June 30, 2019 | 145.31M |
| March 31, 2019 | -65.43M |
| December 31, 2018 | -55.21M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
16.77M
Minimum
Dec 2023
145.31M
Maximum
Jun 2019
92.40M
Average
100.19M
Median
Shareholders Equity (Quarterly) Benchmarks
| Acasti Pharma Inc | 64.68M |
| Aurinia Pharmaceuticals Inc | 377.95M |
| Edesa Biotech Inc | 4.324M |
| Lexaria Bioscience Corp | 6.521M |
| Xenon Pharmaceuticals Inc | 887.70M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 96.00M |
| Total Liabilities (Quarterly) | 56.08M |